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SHORT COMMUNICATION
Short Term Outcome of Patients with Hematochezia and 
Normal Initial Colonoscopic Findings: Do They Really 



















Background: In a significant number of the patients with hematochezia, colonoscopy turns out to be normal and 
therefore is unable to determine the cause of bleeding. This study investigates outcomes and possible necessity 
for further work up in cases of hematochezia with normal colonoscopy. 
 
Methods: Ninety-seven patients with normal colonoscopy were followed for at least one year from the time of 
colonoscopy by regular visits and phone calls. Mortality and recurrent bleeding were recorded as primary end 
points.  Those with recurrent or continued hematochezia were invited for a new visit and further work up.  
 
Results: Among the ninety seven patients, nine cases (9.3%) were lost at follow ups, 10 experienced rebleeding 
(10.3 %), and the remaining 78 (80.4 %) were apparently healthy and had no further complaints. There were two 
mortalities during the follow up, one due to gastric cancer and the other due to cerebrovascular accident.  
 
Conclusion: It is unusual for the cases of hematochezia with a normal initial colonoscopy to have recurrent 
bleeding as a result of a significant missed lesion in the colon. 
 





Hematochezia, the passage of bright red or maroon 
blood from the rectum, usually originates from a 
source in lower parts of the gastrointestinal (GI) tract 
especially in a homodynamically stable patient.
1  The 
numerous aetiologies which may cause hematochezia 
can be grouped into several categories including ana-
tomic (e.g. diverticulosis); vascular (e.g. angiodyspla-
sia, ischemia and radiation-induced); inflammatory 
(e.g. infectious and idiopathic inflammatory bowel dis-
eases); neoplastic causes (e.g. polyp, carcinoma) and 
miscellaneous disorders (e.g. haemorrhoid and solitary 
ulcers ) and rare systemic causes (e.g. vitamin K defi-
ciency and other coagulative disorders).
2-4  
There is an array of para-clinical tests which are 
routinely used to find the cause of bleeding; including 
colonoscopy, RBC scan, angiography and even surgi-
cal exploration in severe cases.
2 Ignoring the surgical 
interventions for obvious reasons, colonoscopy has 
the highest diagnostic yield among the above men-
tioned interventions. It is the selective tool for evalua-
tion of the entire colon for neoplastic and non-
neoplastic sources of bleeding.
5,6 It should be noted 
that the most careful clinical assessment can be even 
unreliable both for determining the site of bleeding 
and for ruling out significant pathology.
7-10 As an ex-
ample, the presence of haemorrhoids does not ex-
clude a more proximal culprit lesion, and could even 
mask the concomitant bleeding of an early neoplasia.
9 
In a significant number of the patients with hema-
tochezia, colonoscopy turns out to be normal and 
therefore is unable to determine the cause of bleeding. 
Most of these cases would stop bleeding spontaneous-
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occur inviting the physician for more intensive work 
up.
2,4 Some of these patients may have more serious 
gastrointestinal (GI) disorders, including vascular 
lesions, GISTs, Crohn‘s disease, intestinal tuberculo-
sis (TB), ischemic colitis and malignancies,
3,4,11-15 
which all are preferred to be distinguished in early 
stages of presentation.
4,11-15  
This study was designed to follow the cases of 
hematochezia with normal colonoscopy and to deter-
mine the prognosis as well as necessity of the further 
work up in such cases. 
 
 
Materials and Methods  
 
All patients aged 15 to 75 years old presenting with 
hematochezia between April 2006 and end of Decem-
ber 2006. All patients were referred to two university 
affiliated clinics of Shiraz University of Medical Sci-
ences, Shiraz, Southern Iran. Complaining of excretion 
of red blood per rectum and a normal total colonosco-
py were the criteria for the patients to be enrolled.  
The exclusion criteria were past medical history of 
any GI disorder which may present with fresh rectal 
bleeding including diverticulosis; vascular abnormali-
ties, radiation-induced pathologies; inflammatory 
bowel disease (IBD); neoplasm and other anorectal 
disorders such as haemorrhoid, ulcer as well as any 
colonoscopic findings which can produce fresh rectal 
bleeding. Ninety-seven patients with normal colonos-
copy were included in then study.  
All patients were firstly visited by a gastroenterol-
ogist. On first visit, a questionnaire was filled for 
each patient during a face-to-face interview about 
the pattern, duration, amount of their rectal bleeding, 
their bowl habit and their past medical history of any 
gastro intestinal and non-gastrointestinal disorders. 
The same questionnaire was also completed on the 
follow up visit of those experiencing rebleeding 
(Figure 1). 
Before the procedure, complete bowel preparation 
was performed for all patients.  At least twelve to fif-
teen hours prior to procedure, patients were instructed 
to drink 280 g of polyethylene glycol powder ( PI-
DROLAX, Sepidag Pharmacologic Company, Karaj, 
Iran) solved in four litter of water in fifteen minutes 
intervals. All colonoscopies were performed using an 
Olympus Q230 or Q240 videocolonope (Olympus 
Co., Tokyo, Japan), by a single expert gastroenterolo-
gist to eliminate any person-to-person variability. The 
completeness of colonoscopy was assured by visuali-
zation of terminal ileum. 
Ninety-seven patients with normal colonoscopy 
were followed for at least one year period from the 
time of colonoscopy. The patients were either seen 
personally in the clinic every three months or, for 
those who did not attend their scheduled visits, fol-
lowed by phone calls. Those with recurrence or con-
tinuation of hematochezia were invited for a new visit 
and further work up. On their visits, history and phys-
ical exam were performed again and colonoscopy was 
done. Data were collected and analyzed with SPSS 
software(Version 15, Chicago, IL, USA), using Stu-











No Re-bleeding Re-bleeding Missed follow up  
Fig. 1: Rebleeding rate in the study group. Follow up of hematochezia patients 
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This study  was approved by constituted Ethics 
Committee of the Shiraz University of Medical Sci-
ences within which the work was undertaken. It also 
conformed to the provisions of the Declaration of 





Baseline characteristics of the patients were outlined 
in Table 1. Among the 97 patients, 9 cases (9.3%) 
were lost at follow ups, 10 experienced rebleeding 
(10.3 %), and the remaining 78 (80.4 %) were appar-
ently healthy and had no further complaints 
(p=0.014). Two patients expired during the follow up, 
one due to gastric cancer (who experienced rebleed-
ing) and the other due to cerebro-vascular accident 
(no re-bleeding). 
 
Table 1: Baseline characteristics of the patients. 
Mean age (year)  48.34 
Sex (male/female)  59/38 
Mean hemoglobin level on presentation 
(mg/dL) 
11.45 




Ten re-bleeding cases were invited for further 
work up; one presented with hematemesis and was 
subsequently diagnosed with gastric cancer, 9 under-
went re-colonoscopy: two (20%) had high grade 
haemorrhoids that were referred to general surgeons 
for haemorrhoidectomy after which their bleeding 
stopped, one (10%) had mild proctitis (not present in 
the first colonoscopy), and the remaining six (60%) 
had normal colonoscopy. There were no statistically 
significant differences between the re-bleeder vs. 
non-rebleeder group in either mean age (p=0.167) or 





Colonoscopy is useful in the investigation of patients 
with hematochezia but it is not successful in diagno-
sis of the aetiology of bleeding in a portion of pa-
tients, some of this group might have episodes of re-
bleeding but most of them do not experience more 
bleeding episodes.
10 Little information is available on 
the rate and predictive factors of rebleeding in those 
cases.
11 There is also little data to show whether a se-
cond look colonoscopy will be of any help. 
In addition to the risk of rebleeding and possible 
associated complications, there is also a legitimate 
concern over possible missed etiologies, which may 
affect the patient’s future well being.
11-15 Our study, 
although small in size, clearly showed that majority 
of these patients (80.4 %) had no further bleeding 
episodes or complications, at least in short term fol-
low ups. From those who completed the study only 2 
of the patients were diagnosed with gastric cancer in 
one year follow up. In those patients who re-bled dur-
ing follow ups, re-colonoscopy rarely showed the 
most feared neoplastic lesions but may elucidate the 
diagnosis and help the treatment in up to one –third of 
the patients. 
Although any casual relation between gastric can-
cer and fresh rectal bleeding is questionable, this oc-
currence emphasized the need for detailed history 
taking as well as follows up in cases of hematochezia 
with undiagnosed aetiology. 
In conclusion, neoplastic lesions of the large bow-
el are rare in patients with hematochezia and normal 
initial colonoscopy. According to the results of this 
study there is no need for further screening methods 
in patients with hematochazia at least during the first 
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